Riskpilot← Back to searchSign inGet full accessWimar Medical AB
ABActiveOrg 5591788269Karlsholmsvägen 11Hospital activities · NACE 8610Est. 20180 employees
Revenue 2025
SEK 377K
-28% vs 2024
EBITDA margin
87.3%
-30% vs 2024
Equity ratio
64.8%
Financial strength
Net profit 2025
SEK 217K
-36% vs 2024
| Revenue | SEK 377K | -28% |
| EBITDA | SEK 329K | -30% |
| Net profit | SEK 217K | -36% |
| Total assets | SEK 1,1M | +29% |
| Equity | SEK 712K | +44% |
| Employees | 0 | — |
Legal name
Wimar Medical AB
Org number
5591788269
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
7 november 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Konsultverksamhet och uppdrag inom hälso- och sjukvårdssektorn. Utveckling av medicinsk teknik. Rehabilitering.
Address
Karlsholmsvägen 11
Email
wimarmedical@wimmercranz.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 199 | 476 | 400 | 521 | 377 |
| Staff expenses | — | −30 | −11 | −11 | −10 |
| EBITDA | 163 | 401 | 323 | 470 | 329 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 163 | 401 | 323 | 470 | 329 |
| Net financials | — | −0 | 3 | 62 | 7 |
| Profit before tax | 162 | 301 | 246 | 431 | 275 |
| Tax | −33 | −63 | −51 | −90 | −58 |
| Net profit | 129 | 238 | 195 | 341 | 217 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 296 | 649 | 932 | 848 | 1 097 |
| Equity | 221 | 459 | 653 | 495 | 712 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 46 | 61 | 70 | 44 | 16 |
| Total debt | 46 | 61 | 70 | 44 | 16 |
EBITDA margin
87.3%
This company
15.8%
Market median
+453% vs market
20212025
Equity ratio
64.8%
This company
38.2%
Market median
+70% vs market
20212025
Return on equity
30.5%
This company
18.4%
Market median
+66% vs market
20212025
Net profit margin
57.6%
This company
8.1%
Market median
+611% vs market
20212025
Asset turnover
0.34×
This company
1.12×
Market median
-70% vs market
20212025
Debt / equity
0.54×
This company
0.62×
Market median
+13% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Wimar Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulrika Kristina Wimmercranz Marking | Chairman | 0 companies |
| Olof Fredrik Wimmercranz | Board of Directors | 0 companies |
| Anders Christer Marking | Deputy Board Member | 0 companies |
| Lena Margareta Olofsson | Deputy Board Member | 0 companies |